Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹83.16Admitted-Finance | ₹83.16 | L1 | Admitted-Finance |
| 2 | L2₹89.25+₹6.09 (7.32%)Admitted-Finance | ₹89.25+₹6.09 (7.32%) | L2 | Admitted-Finance |
| 3 | L3₹210+₹126.84 (152.5%)Admitted-Finance | ₹210+₹126.84 (152.5%) | L3 | Admitted-Finance |
| 4 | L4₹252+₹168.84 (203.0%)Admitted-Finance | ₹252+₹168.84 (203.0%) | L4 | Admitted-Finance |
| 5 | L5₹600.43+₹517.27 (622.0%)Admitted-Finance 18 1AND3 AZAMABAD HYDERABAD HYDERABAD TELANGANA 500020 | HYDERABAD | TELANGANA | 500020 | ₹600.43+₹517.27 (622.0%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Intas Pharmaceuticals limited L9 | Alpha Drugs L6 | Reliance Life Sciences Pvt. Ltd. L8 | Novo Nordisk India Private Limited L10 | SERUM INSTITUTE ON INDIA PVT LTD L4 | Vim Meditech Pvt.Ltd. L2 | Takeda Biopharmaceuticals India Private Limited L11 | Protech Telelinks L1 | BIOLOGICAL E LTD L5 | CHIRON BEHRING VACCINES PRIVATE LIMITED L3 | BHARAT SERUMS AND VACCINES LIMITED L7 | Roche Products (India) Pvt Ltd L12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Dried Factor VII Fraction (IV use) 1mg | 1 | Vial | - | - | - | 39,310 ₹41,275.5 Lowest | - | - | - | - | - | - | - | - |
| 2.00 | Dried Factor VIII Fraction (IV use)250IU | 1 | Vial | - | 1,950 ₹2,047.5 | 1,265 ₹1,328.25 Lowest | - | - | - | 2,687.5 ₹2,821.87 | - | - | - | - | - |
| 3.00 | Dried Factor VIII Fraction (IV use)500IU | 1 | Vial | - | - | 2,640 ₹2,772 Lowest | - | - | - | - | - | - | - | - | - |
| 4.00 | Dried Factor VIII Fraction (IV use)1000IU | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - |
| 5.00 | Factor IX Concentrate 500/600 IU | 1 | Vial | 6,300 ₹6,615 | - | - | - | - | - | 5,904 ₹6,199.2 Lowest | - | - | - | - | - |
| 6.00 | Anti- Inhibitor Coagulation Complex[Human Plasma Protein with a Factor VIII Inhibitor Bypassing Activity of All Strength. | 1 | Vial | - | - | - | - | - | - | 59,000 ₹61,950 Lowest | - | - | - | - | - |
| 7.00 | Recombinant Factor VIII 250 IU | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - |
| 8.00 | Recombinant Factor VIII 500 IU | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - |
| 9.00 | Recombinant Factor VIII 1500 IU | 1 | Vial | - | - | - | 12,000 ₹12,600 Lowest | - | - | - | - | - | - | - | - |
| 10.00 | Recombinant Factor VIII 1000 IU | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
18 Nov 2024, 3:00 pmClosed
The Director General,MH and FW Uttarakhand
DGMHFW, Danada Lakhond, Shastradhara Road, Dehradun
Procurement of medicine under Rate contract for various Hospital of Uttarakhand at F.O.R destination
2024_MHFW_77069_1
15P/Store/50/2024/25757
Open Tender
Medicines
Item Wise
42 days
DGMHFW, Danada Lakhond, Shastradhara Road, Dehradu
Please refer Tender documents.
4 documents required · 4 mandatory
₹1,000
The Director General,MH and FW Uttarakhand
₹1 L
4 Dec 2024
17 Oct 2024
18 Nov 2024
17 Oct 2024
18 Nov 2024
18 Oct 2024
Dried Factor VII Fraction (IV use) 1mg
Dried Factor VIII Fraction (IV use)250IU
Dried Factor VIII Fraction (IV use)500IU
Dried Factor VIII Fraction (IV use)1000IU
Factor IX Concentrate 500/600 IU
Anti- Inhibitor Coagulation Complex[Human Plasma Protein with a Factor VIII Inhibitor Bypassing Activity of All Strength.
Recombinant Factor VIII 250 IU
Recombinant Factor VIII 500 IU
Recombinant Factor VIII 1500 IU
Recombinant Factor VIII 1000 IU
Long Acting Factor IX - Extended Half Life 500 IU
Elongated Half Life rFVIII for treatment of Hemophilia A Patients
Rurioctocag Alfa pegol (PEGylated) recombinant human factor VIII 500 IU
Recombinant Human Anti D Immunoglobulin 150 mcg
Recombinant Human Anti D Immunoglobulin Injection (IM use) 300 mcg
Anti- Inhibitor Coagulation Complex[Human Plasma Protein with a Factor VIII Inhibitor Bypassing Activity of 500 IU
Snake Venom Anti Serum (Polyvalent Anti Snake Venom) Lyophillized
Rabies Vaccine Human (Cell Culture) (Intradermal) 2.5 IU (chick embryo)
Injection Low Molecular Weight Heparin 40mg/0.4ml
Emicizumab 30 mg
Emicizumab 60 mg
Vim Meditech Pvt.Ltd. (BID ID -343126)
CHIRON BEHRING VACCINES PRIVATE LIMITED (BID ID -342145)
SERUM INSTITUTE ON INDIA PVT LTD (BID ID -340977)
BIOLOGICAL E LTD (BID ID -342316)
Alpha Drugs (BID ID -342045)
BHARAT SERUMS AND VACCINES LIMITED (BID ID -340903)
Reliance Life Sciences Pvt. Ltd. (BID ID -342447)
Intas Pharmaceuticals limited (BID ID -341597)
Novo Nordisk India Private Limited (BID ID -342775)
Takeda Biopharmaceuticals India Private Limited (BID ID -344497)
Roche Products (India) Pvt Ltd (BID ID -342034)
Roche Products (India) Pvt Ltd
CHIRON BEHRING VACCINES PRIVATE LIMITED
BIOLOGICAL E LTD
Reliance Life Sciences Pvt. Ltd.
Vial with diluent03
Novo Nordisk India Private Limited
Vial with diluent09
Protech Telelinks
Takeda Biopharmaceuticals India Private Limited
Vial with 20ml solvent06
Vial with diluent13
Vial with 20ml solvent16
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .